Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
European Cytokine Network
|
January 10, 2002
Monocyte chemotactic protein-3
P Menten, A Wuyts, J Van Damme
Blood
|
August 29, 2000
Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist
P Proost, P Menten, S Struyf, et al.
Human Gene Therapy
|
March 21, 2000
Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice
A Haag, P Menten, J Van Damme, et al.
Journal of Virology
|
April 5, 2001
The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages
S Aquaro, P Menten, S Struyf, et al.
The Journal of Clinical Investigation
|
August 17, 1999
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine
P Menten, S Struyf, E Schutyser, et al.
Biochemistry
|
November 23, 2000
Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages
A Wuyts, E Schutyser, P Menten, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 18, 2000
Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells
E Schutyser, S Struyf, P Menten, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 29, 1998
Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor
P Proost, S Struyf, M Couvreur, et al.
European Journal of Immunology
|
May 16, 1998
Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor
S Struyf, I De Meester, S Scharpé, et al.
Chemical Immunology
|
November 7, 1999
The role of CD26/DPP IV in chemokine processing
J Van Damme, S Struyf, A Wuyts, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
European Cytokine Network
|
January 10, 2002
Monocyte chemotactic protein-3
P Menten, A Wuyts, J Van Damme
Blood
|
August 29, 2000
Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist
P Proost, P Menten, S Struyf, et al.
Human Gene Therapy
|
March 21, 2000
Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice
A Haag, P Menten, J Van Damme, et al.
Journal of Virology
|
April 5, 2001
The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages
S Aquaro, P Menten, S Struyf, et al.
The Journal of Clinical Investigation
|
August 17, 1999
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine
P Menten, S Struyf, E Schutyser, et al.
Biochemistry
|
November 23, 2000
Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages
A Wuyts, E Schutyser, P Menten, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 18, 2000
Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells
E Schutyser, S Struyf, P Menten, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 29, 1998
Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor
P Proost, S Struyf, M Couvreur, et al.
European Journal of Immunology
|
May 16, 1998
Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor
S Struyf, I De Meester, S Scharpé, et al.
Chemical Immunology
|
November 7, 1999
The role of CD26/DPP IV in chemokine processing
J Van Damme, S Struyf, A Wuyts, et al.
Page
of 2